MBBS in Uzbekistan Not Banned: HMC and Indian Embassy Clarify What the NMC Advisory Really Means

The Haryana Medical Council (HMC) and the Embassy of India in Tashkent clarified on July 28, 2026, that the National Medical Commission (NMC) advisory issued April 1, 2026, concerning medical universities in Uzbekistan should not be interpreted as an admission ban. The clarification followed social media posts that raised concerns over admissions to Bukhara State Medical Institute, Samarkand State Medical University and Tashkent State Medical University.

The Indian Embassy in Tashkent said the NMC advisory was precautionary and urged students and parents to rely on official information when making admission decisions.

The HMC clarified that its advisory concerning the three Uzbekistan medical universities “should not be read as a ban on admissions,” according to the clarification reported by Times of India.

The council advised students to verify the recognition status of their chosen university, comply with the NMC Foreign Medical Graduate Licentiate (FMGL) Regulations, 2021, and check all mandatory requirements before enrolling.

The Embassy of India in Tashkent separately clarified that the NMC’s April 1, 2026, advisory was precautionary and did not amount to a ban on the universities concerned. The embassy said it was coordinating with the three institutions on student intake norms, clinical training requirements and applicable NMC regulations.

The embassy also advised students and parents not to rely on rumors, misleading videos or unverified social media posts when making admission decisions.

According to the NMC advisory, the matter was brought to the Commission’s attention through a communication from the Embassy of India in Tashkent.

The communication cited reports that students were being admitted beyond approved intake capacity, raising concerns about the quality of medical education and training.

It also referred to difficulties with hands-on clinical training, including communication challenges where the medium of instruction was not English. The communication further mentioned complaints alleging violations of the FMGL Regulations, 2021, involving the Tashkent State Medical University (TSMU) Termez Branch in Uzbekistan and TIT Institute of Medical Sciences, Bengaluru, described in the source as an offshore campus arrangement.

The Embassy also shared testimonies from Indian students studying at Bukhara State Medical University through a private contractor identified as RARE Company.

These were concerns communicated to the NMC; the advisory itself should not be presented as a finding that every allegation had been conclusively established.

The HMC’s clarification concerning three Uzbekistan medical universities does not change its earlier advisory against admissions to certain other medical institutions. The council reiterated that the previous advisory remains in effect for the institutions it had identified.

The institutions listed under the earlier advisory are:

• Central American Health and Sciences University

• Columbus Central University

• Washington University of Health and Sciences in Belize

• Chirchiq Branch of Tashkent State Medical University, Uzbekistan

The distinction is relevant for Indian students considering MBBS abroad. The clarification concerning Bukhara State Medical Institute, Samarkand State Medical University and Tashkent State Medical University should not be interpreted as withdrawing the HMC’s separate advisory covering the institutions listed above.

Also see: NMC Panel to Review 3 New DM Feeder Pathways: MD Biochemistry, MD Emergency Medicine, and MD Tropical Medicine

For Indian students planning MBBS in Uzbekistan, the HMC and Embassy of India’s clarification does not remove the need for due diligence. Admission decisions should be based on the current status of the specific medical institution and official regulatory information.

Before enrolling, students and parents should:

• Check the university’s recognition status and applicable NMC requirements.

• Confirm compliance with the NMC FMGL Regulations, 2021, including the requirements relevant to foreign medical graduates.

• Verify intake capacity and clinical training arrangements before paying admission fees.

• Confirm the language of instruction, particularly for medical and clinical training.

• Rely on official information from the NMC, Embassy of India and competent government authorities rather than unverified social media posts or promotional claims.

The NMC’s official records list the Uzbekistan advisory under April 1, 2026, confirming the date of the Commission’s notice.

For Indian students planning to study medicine abroad, the key takeaway is that an advisory should not automatically be interpreted as an admission ban. Students should establish the current regulatory position of the specific institution before paying fees or enrolling.

 References:

1. National Medical Commission. “Advisory for Indian Students Seeking Admission to Foreign Institutes/Universities for Undergraduate Medical Courses in Uzbekistan.” April 1, 2026. https://www.nmc.org.in/MCIRest/open/getDocument?path=/Documents/Public/Portal/LatestNews/Adveisry_merged_admninforeignUniv.pdf

2. Ministry of External Affairs, Government of India. “Alert Issued by NMC against Foreign Medical Institutions.” Accessed August 11, 2026. https://www.mea.gov.in/images/pdf/Alert-issued-by-NMC-against-Foreign-Medical-Insititions.pdf

(Rh/TP/MSM)